4//SEC Filing
Boenisch Sandra 4
Accession 0001731122-21-001126
CIK 0001314052other
Filed
Jun 30, 8:00 PM ET
Accepted
Jul 1, 9:45 PM ET
Size
15.7 KB
Accession
0001731122-21-001126
Insider Transaction Report
Form 4
Boenisch Sandra
PFO & Treasurer
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2021-06-29−25,000→ 0 totalExercise: $5.68Exp: 2025-10-02→ Common Stock (25,000 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2021-06-29−35,000→ 0 totalExercise: $5.92Exp: 2027-05-12→ Common Stock (35,000 underlying) - Exercise/Conversion
Common Stock
2021-06-29$3.28/sh+106,696$349,963→ 154,659 total - Exercise/Conversion
Stock Option (Right to Buy)
2021-06-29−106,696→ 0 totalExercise: $3.28From: 2016-09-22Exp: 2026-09-22→ Common Stock (106,696 underlying) - Exercise/Conversion
Common Stock
2021-06-29$5.68/sh+25,000$142,000→ 47,963 total - Sale
Common Stock
2021-06-29$26.53/sh−166,696$4,422,445→ 22,963 total - Exercise/Conversion
Common Stock
2021-06-29$5.92/sh+35,000$207,200→ 189,659 total
Footnotes (2)
- [F1]The options subject to this grant vested quarterly over a three-year period commencing on December 31, 2015.
- [F2]The options subject to this grant vested quarterly over a three-year period commencing on June 30, 2017.
Documents
Issuer
ANAVEX LIFE SCIENCES CORP.
CIK 0001314052
Entity typeother
Related Parties
1- filerCIK 0001655366
Filing Metadata
- Form type
- 4
- Filed
- Jun 30, 8:00 PM ET
- Accepted
- Jul 1, 9:45 PM ET
- Size
- 15.7 KB